[go: up one dir, main page]

FR2848553B1 - Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques - Google Patents

Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques

Info

Publication number
FR2848553B1
FR2848553B1 FR0215751A FR0215751A FR2848553B1 FR 2848553 B1 FR2848553 B1 FR 2848553B1 FR 0215751 A FR0215751 A FR 0215751A FR 0215751 A FR0215751 A FR 0215751A FR 2848553 B1 FR2848553 B1 FR 2848553B1
Authority
FR
France
Prior art keywords
cosmetic
pharmaceutical compositions
modulating compounds
ppary receptors
novel modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0215751A
Other languages
English (en)
Other versions
FR2848553A1 (fr
Inventor
Laurence Clary
Pascal Collette
Michel Rivier
Andre Jomard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0215751A priority Critical patent/FR2848553B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to KR1020057010555A priority patent/KR20050089037A/ko
Priority to PL376737A priority patent/PL376737A1/pl
Priority to CA002506732A priority patent/CA2506732A1/fr
Priority to RU2005121907/04A priority patent/RU2005121907A/ru
Priority to CNA2003801053059A priority patent/CN1723193A/zh
Priority to JP2004558089A priority patent/JP2006509798A/ja
Priority to PCT/EP2003/015010 priority patent/WO2004052840A1/fr
Priority to EP03808292A priority patent/EP1572629A1/fr
Priority to MXPA05006081A priority patent/MXPA05006081A/es
Priority to BR0316193-5A priority patent/BR0316193A/pt
Priority to AU2003302909A priority patent/AU2003302909A1/en
Priority to ARP030104594A priority patent/AR042625A1/es
Publication of FR2848553A1 publication Critical patent/FR2848553A1/fr
Priority to ZA200504263A priority patent/ZA200504263B/en
Priority to US11/149,551 priority patent/US7125869B2/en
Priority to US11/523,701 priority patent/US7307078B2/en
Application granted granted Critical
Publication of FR2848553B1 publication Critical patent/FR2848553B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/66—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems and singly-bound oxygen atoms, bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0215751A 2002-12-12 2002-12-12 Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques Expired - Fee Related FR2848553B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0215751A FR2848553B1 (fr) 2002-12-12 2002-12-12 Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
BR0316193-5A BR0316193A (pt) 2002-12-12 2003-12-11 Composto, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
CA002506732A CA2506732A1 (fr) 2002-12-12 2003-12-11 Nouveaux composes modulateurs des recepteurs de type ppar.gamma. et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
RU2005121907/04A RU2005121907A (ru) 2002-12-12 2003-12-11 Новые соединения, являющиеся модуляторами рецепторов типа pparгамма, и их применение в косметических или фармацевтических композициях
CNA2003801053059A CN1723193A (zh) 2002-12-12 2003-12-11 调节PPARγ型受体的化合物及其在化妆品或药用组合物中的用途
JP2004558089A JP2006509798A (ja) 2002-12-12 2003-12-11 ＰＰＡＲγ型受容体を調節する新規化合物、および化粧品組成物または医薬組成物におけるその使用
PCT/EP2003/015010 WO2004052840A1 (fr) 2002-12-12 2003-12-11 Nouveaux composes modulateurs des recepteurs de type ppar$g(g), et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
EP03808292A EP1572629A1 (fr) 2002-12-12 2003-12-11 Nouveaux composes modulateurs des recepteurs de type ppar$g(g), et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
KR1020057010555A KR20050089037A (ko) 2002-12-12 2003-12-11 ＰＰＡＲγ 형 수용체를 조절하는 화합물, 및 미용 또는약학 조성물에서의 이의 용도
PL376737A PL376737A1 (pl) 2002-12-12 2003-12-11 Związki, które modulują receptory typu PPAR<$Egamma> i ich zastosowanie w kompozycjach kosmetycznych lub farmaceutycznych
AU2003302909A AU2003302909A1 (en) 2002-12-12 2003-12-11 COMPOUNDS WHICH MODULATE PPARGamma TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
MXPA05006081A MXPA05006081A (es) 2002-12-12 2003-12-11 Nuevos compuestos moduladores de los receptores de tipo receptor activado proliferador de peroxisoma del subtipo (ppar gamma) y su uso en composiciones cosmeticas o farmaceuticas.
ARP030104594A AR042625A1 (es) 2002-12-12 2003-12-12 Compuestos moduladores de los receptores de tipo ppar gamma
ZA200504263A ZA200504263B (en) 2002-12-12 2005-05-25 Compounds which modulate pparytype receptors, and use thereof in cosmetic or pharmaceutical.
US11/149,551 US7125869B2 (en) 2002-12-12 2005-06-10 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
US11/523,701 US7307078B2 (en) 2002-12-12 2006-09-20 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215751A FR2848553B1 (fr) 2002-12-12 2002-12-12 Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques

Publications (2)

Publication Number Publication Date
FR2848553A1 FR2848553A1 (fr) 2004-06-18
FR2848553B1 true FR2848553B1 (fr) 2007-03-30

Family

ID=32338740

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0215751A Expired - Fee Related FR2848553B1 (fr) 2002-12-12 2002-12-12 Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques

Country Status (4)

Country Link
CN (1) CN1723193A (fr)
AR (1) AR042625A1 (fr)
FR (1) FR2848553B1 (fr)
ZA (1) ZA200504263B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862870A1 (fr) * 2003-12-01 2005-06-03 Galderma Res & Dev Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie.
DE602005010444D1 (de) * 2004-08-17 2008-11-27 Galderma Res & Dev Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
FR2878247B1 (fr) 2004-11-19 2008-10-03 Galderma Res & Dev Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
EP1814871B1 (fr) * 2004-11-19 2011-03-02 Galderma Research & Development Nouveaux composes de modulation des recepteurs de type pparg, et utilisation dans des compositions cosmetiques ou pharmaceutiques
WO2007070523A2 (fr) * 2005-12-13 2007-06-21 The Procter & Gamble Company Compositions pour soins personnels
CN104611645B (zh) * 2014-12-29 2018-09-21 芜湖金龙模具锻造有限责任公司 一种耐高温合金模具钢

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739169A (en) * 1996-05-31 1998-04-14 Procept, Incorporated Aromatic compounds for inhibiting immune response
FR2812876B1 (fr) * 2000-08-08 2002-09-27 Galderma Res & Dev Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques

Also Published As

Publication number Publication date
AR042625A1 (es) 2005-06-29
ZA200504263B (en) 2006-02-22
CN1723193A (zh) 2006-01-18
FR2848553A1 (fr) 2004-06-18

Similar Documents

Publication Publication Date Title
FR2812876B1 (fr) Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
FR2834718B1 (fr) Substances actives cosmetiques et/ou pharmaceutiques
EP1765379A4 (fr) Compositions pharmaceutiques de co-cristal et methodes d&#39;utilisation associees
FR2878439B1 (fr) Nouveaux derives n-acyles d&#39;aminoacides et leur utilisation en cosmetique et en pharmacie
DE60036401D1 (de) Kosmetische mittel enthaltend anis-extrakt und retinoide
FR2848553B1 (fr) Nouveaux composes modulateurs des recepteurs de type ppary et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l&#39;enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
FR2841550B1 (fr) Nouvelles molecules derivees de la tyramine, leur mode de preparation, et leur utilisation seules ou associees dans des compositions cosmetiques ou dermopharmceutiques
FR2874378B1 (fr) Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
FR2874379B1 (fr) Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
FR2920769B1 (fr) Nouveaux derives de n-phenyl acetamide, inhibiteurs de l&#39;enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant
DE10195737T1 (de) Hautgummiermittel und kosmetische Formulierungen
FR2847251B1 (fr) NOUVEAUX COMPOSES BI-AROMATIQUES ACTIVEURS DES RECEPTEURS DE TYPE PPARy ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
FR2856401B1 (fr) Nouveaux composes modulateurs des recepteurs de type ppargamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
FR2855410B1 (fr) Composition cosmetique pour le maquillage et/ou le soin de la peau, notamment du visage.
FR2892020B1 (fr) Composition comprenant la lauroyl proline et du laurate de sorbitan et ses utilisations dans les formulations cosmetiques et pharmaceutiques comme actif lipolytique pour une action amincissante ou anti-cellulite
FR2776659B1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
FR2847580B1 (fr) NOUVEAUX COMPOSES BI-AROMATIQUES ACTIVATEURS DES RECEPTEURS DE TYPE PPARy ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
FR2850968B1 (fr) NOUVEAUX COMPOSES MODULATEURS DES RECEPTEURS DE TYPE PPARs ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
FR2850967B1 (fr) NOUVEAUX COMPOSES MODULATEURS DES RECEPTEURS DE TYPE PPARs ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
FR2863610B1 (fr) NOUVEAUX COMPOSES MODULATEURS DES RECEPTEURS DE TYPE PPARs ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
FR2869903B1 (fr) Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppary, leur procede de preparation et leur utilisation dans les compositions cosmetiques ou pharmaceutiques
FR2829695B1 (fr) Utilisation de la seve de bouleau dans des compositions cosmetiques et dermopharmaceutiques
FR2840805B1 (fr) Utilisation de polymeres du methacrylate de methyle comme agent de texture dans des compositions cosmetiques ou pharmaceutiques et compositions les contenant
EP1854475A4 (fr) Utilisation de la leptine dans la prevention d&#39;une surcharge ponderale et composition contenant de la leptine

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20090831